MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jnci/djag306

Медицинская библиотека · Journal of the National Cancer Institute · 2026

Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

Srinivasan Aparna, Wang Jian, Matt Gavriel, Mills Lauren J, Sapkota Yadav, Wang Zhaoming, Yang Tianzhong, Neglia Joseph P, Turcotte Lucie M, Hudson Melissa M, Ness Kirsten K, Armstrong Gregory T, Zhang Jinghui, Robison Leslie L, Zhou Xin, Yasui Yutaka, Im Cindy

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Female survivors of childhood cancer are at high risk for developing breast cancer. The contributions of most general population primary breast cancer genetic predictors to this risk have not been explored.

METHODS

Analyses included females who survived ≥5 years after their childhood cancer diagnosis with available array (N = 2096, subsequent breast cancer [SBC]=218) or whole-genome sequencing (WGS; N = 3292, SBC=101) data from the Childhood Cancer Survivor Study and St. Jude Lifetime Cohort. We computed 99 externally-validated primary breast cancer polygenic risk scores (PRS). Using deep-coverage WGS, ClinVar-annotated pathogenic/likely pathogenic (P/LP) variants in breast cancer susceptibility genes were identified. Cox proportional hazards models assessed associations with SBC risk, adjusting for treatments and genetic ancestry.

RESULTS

Among 5388 female survivors (genetic ancestry, European: N = 4,752; African: N = 444; East Asian: N = 192), 319 developed SBC. Most (90.9%) PRSs were nominally associated with SBC risk (P < 0.05), but effect sizes varied substantially. PRSs with superior discriminatory ability had greater genome-wide coverage (e.g., 6.4 million-variant PRS, HR per SD = 1.71, 95% CI = 1.43 to 2.05; P = 4.2x10-9) and 7.7-fold higher odds (P = 7.0x10-4) of including variants in multiple DNA damage repair pathways compared with PRSs with weaker risk associations. Among survivors with WGS, 1.6% carried P/LP variants in clinical testing panel genes, which was associated with a 7.4-fold greater risk (95% CI = 3.16 to 17.19). Including genetic factors improved SBC risk prediction by age 40 (P < 0.001) compared to treatment exposures alone.

CONCLUSIONS

Externally-validated primary breast cancer genetic susceptibility predictors are relevant for SBC risk prediction and should be prioritized for risk stratification in survivors.

Для цитирования: Srinivasan Aparna, Wang Jian, Matt Gavriel, Mills Lauren J, Sapkota Yadav, Wang Zhaoming, Yang Tianzhong, Neglia Joseph P, Turcotte Lucie M, Hudson Melissa M, Ness Kirsten K, Armstrong Gregory T, Zhang Jinghui, Robison Leslie L, Zhou Xin, Yasui Yutaka, Im Cindy. Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.. Journal of the National Cancer Institute. 2026. DOI: 10.1093/jnci/djag306.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.